Mice bearing a human Myc transgene driven by the hepatocyte-specific, doxycycline-suppressible LAP-promoter [19, 24], were placed on NFDs, MC-HFDs or LC-HFDs one week prior to Myc induction and maintained on these continuously during the course of HCC development. The gene discussed is MYC; the disease is hepatocellular carcinoma.